ACLY Antikörper
-
- Target Alle ACLY Antikörper anzeigen
- ACLY (ATP Citrate Lyase (ACLY))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser ACLY Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Full length human recombinant protein of human ACLY (NP_001087) produced in HEK293T cell.
- Klon
- 3G8
- Isotyp
- IgG1
- Top Product
- Discover our top product ACLY Primärantikörper
-
anti-ATP Citrate Lyase (ACLY) (AA 306-502) antibody
ACLY Reaktivität: Human, Maus, Ratte, Affe WB, ELISA, IHC, FACS, ICC Wirt: Maus Monoclonal 5F8D11 unconjugated
anti-ATP Citrate Lyase (ACLY) (AA 752-1101) antibodyACLY Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-ATP Citrate Lyase (ACLY) (pSer455) antibodyACLY Reaktivität: Human WB, IHC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-ATP Citrate Lyase (ACLY) (AA 306-502) antibodyACLY Reaktivität: Human, Maus, Ratte, Affe WB, ELISA, IHC, FACS, IF/ICC Wirt: Maus Monoclonal unconjugated
anti-ATP Citrate Lyase (ACLY) (AA 4-265) antibodyACLY Reaktivität: Human WB, ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-ATP Citrate Lyase (ACLY) antibodyACLY Reaktivität: Human WB, ELISA, IF, FACS Wirt: Kaninchen Monoclonal 3A5 unconjugated Recombinant Antibody
anti-ATP Citrate Lyase (ACLY) (C-Term) antibodyACLY Reaktivität: Human, Maus WB, FACS, ICC Wirt: Maus Monoclonal unconjugated
anti-ATP Citrate Lyase (ACLY) (Middle Region) antibodyACLY Reaktivität: Human, Maus, Ratte, Schwein, Rind (Kuh), Zebrafisch (Danio rerio), Kaninchen, Schaf, Hund, Pferd WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-ATP Citrate Lyase (ACLY) (Ser1227) antibodyACLY Reaktivität: Human, Maus, Ratte, Affe WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-ATP Citrate Lyase (ACLY) antibodyACLY Reaktivität: Human, Maus, Ratte ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:2000, IHC 1:50, IF 1:100,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
- Target
- ACLY (ATP Citrate Lyase (ACLY))
- Andere Bezeichnung
- ACLY (ACLY Produkte)
- Synonyme
- ACLY antikoerper, DDBDRAFT_0205389 antikoerper, DDBDRAFT_0235360 antikoerper, DDB_0205389 antikoerper, DDB_0235360 antikoerper, ACL antikoerper, BcDNA:LD21334 antikoerper, CG8322 antikoerper, DmATPCL antikoerper, Dmel\\CG8322 antikoerper, anon-WO0140519.179 antikoerper, dATPCL antikoerper, l(2)01466 antikoerper, l(2)k09217 antikoerper, n(2)k09217 antikoerper, ATPCL antikoerper, CLATP antikoerper, A730098H14Rik antikoerper, AW538652 antikoerper, Clatp antikoerper, acly antikoerper, cb722 antikoerper, zgc:92008 antikoerper, ATP citrate lyase antikoerper, ATP citrate lyase S homeolog antikoerper, ATP-citrate synthase antikoerper, citrate synthase, mitochondrial antikoerper, atp-citrate synthase antikoerper, ATP citrate lyase a antikoerper, ACLY antikoerper, acly.S antikoerper, LOC587157 antikoerper, acly antikoerper, ATPCL antikoerper, LOC5564509 antikoerper, CpipJ_CPIJ010291 antikoerper, Bm1_26245 antikoerper, ACL antikoerper, Acly antikoerper, aclya antikoerper
- Molekulargewicht
- 120.8 kDa
- Gen-ID
- 47
- NCBI Accession
- NM_001096
- HGNC
- 47
- Pathways
- Warburg Effekt
-
